Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital

Does vascular endothelial dysfunction play a role in physical frailty and sarcopenia? A systematic review

Research output: Contribution to journalReviewResearchpeer-review


  1. PaTH Forward: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of TransCon PTH in Adult Hypoparathyroidism

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Denosumab vs. zoledronic acid treatment in post-menopausal breast cancer: a 2-year prospective observational study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Concomitant familial hypocalciuric hypercalcemia and single parathyroid adenoma: a case report

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Anjalee Thanuja Amarasekera
  • Dennis Chang
  • Peter Schwarz
  • Timothy C Tan
View graph of relations

BACKGROUND: Frailty is strongly associated with adverse cardiovascular outcomes; however, the underlying pathophysiological processes are largely unknown. Vascular endothelial dysfunction (VED) is the earliest stage of cardiovascular disease (CVD) progression and predicts long-term CVD outcomes. Both these conditions share an elevated inflammatory state as a common pathological factor.

OBJECTIVE: Systematic literature review was conducted to examine the evidence supporting an association between VED and physical frailty and/or sarcopenia, in electronic databases including Scopus, Ovid Medline, CINAHL, ScienceDirect, ProQuest Health & Medicine and Embase from January 1980 to August 2019.

RESULTS: A total of 18 studies met the inclusion criteria. VED is independently associated with increased frailty phenotypes and measures of sarcopenia. Several markers of VED, including higher levels of asymmetric dimethylarginine, abnormal ankle brachial index, pulse wave velocity, pulse pressure and lower levels of flow-mediated dilatation, peripheral blood flow and endothelial progenitor cell counts, have been associated with frailty/sarcopenia measurements. Some studies demonstrated the effect of inflammation on the association.

CONCLUSIONS: Recent studies, although limited, showed that VED could be one of the underlying mechanisms of frailty. It is entirely possible that inflammation-related pathological changes in the vascular endothelium are involved in the early causative mechanisms in physical frailty. The exact mechanism(s) underlying this association are still unclear and will need to be evaluated. The outcomes of these future research studies could potentially inform early preventative strategies for physical frailty and sarcopenia.

Original languageEnglish
JournalAge and Ageing
Issue number3
Pages (from-to)725-732
Number of pages8
Publication statusPublished - 5 May 2021

    Research areas

  • Ageing, Frailty, Inflammation, Muscle Weakness, Older People, Sarcopenia, Vascular Endothelial Dysfunction

ID: 61435976